RSL3 Promotes STAT3 Ubiquitination to Induce Autophagy and Apoptosis in PARPi-Resistant Breast Cancer Cells
Our findings highlight RSL3 as a promising therapeutic agent and STAT3 as a potential target for treating PARPi-resistant breast cancer.
Institutions
- Wenzhou Medical University (CN)
Publication Details
- Journal
- Biomolecules
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3390/biom15121749
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00